Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its once-monthly twin GLP-1/ GIP receptor agonist, ending (PDF) adva...

Daiichi pays out Merck $170M to create bronchi cancer T-cell engager deal

.Merck &amp Co. has actually promptly recovered a few of the prices of its own Harp on Rehabs purcha...

BioMarin stops preclinical genetics therapy for heart condition

.After BioMarin conducted a spring well-maintained of its pipe in April, the business has actually d...

Eisai plants molecular glue SEED with $1.5 B biobucks handle

.Big Pharmas remain stuck to the tip of molecular adhesive degraders. The latest company to view an ...

Life scientific research credit score firm introduces with $600M

.A brand-new international lifestyle scientific research credit report agency, dubbed Symbiotic Fund...

BMS channels TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing an additional huge wager coming from the Caforio era, terminating a b...

Nuvation standstills BET prevention after considering period 1 information

.After having a look at phase 1 data, Nuvation Biography has actually chosen to stop work on its sin...

' Medical intuitiveness' led FDA specialists to back Zevra's uncommon health condition med

.Zevra Therapies' rare disease drug appears to be on the course to approval this autumn after obtain...

Pfizer takes $230M reached after axing fell short DMD genetics therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics treatment failure has gone a $230 milli...

AC Immune observes 'site' potential in Alzheimer's drug records

.After greater than two decades of work with neurodegenerative ailments, Swiss biotech AC Immune cla...